{"product_id":"rapid-dna-testing-laboratories-kpi-metrics","title":"Financial KPIs for Rapid DNA Testing Labs","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Rapid DNA Testing\u003c\/h2\u003e\n\u003cp\u003eYou must focus immediately on capacity utilization and gross margin, not just top-line revenue, to manage the high fixed costs of Rapid DNA Testing Initial capital expenditure (CAPEX) is heavy, exceeding $29 million for instruments and lab build-out, meaning you defintely need strong cash controls While the model shows a fast break-even in 1 month, you must fund a minimum cash need of -$1,305,000 by June 2026 COGS starts low, around 120% of revenue, giving you a strong gross margin to cover the $49,000 monthly fixed overhead Review utilization rates (like the 500% starting rate for Case Management) weekly to ensure profitability in 2026\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eRapid DNA Testing\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eGross Margin Percentage\u003c\/td\u003e\n\u003ctd\u003eProfitability\u003c\/td\u003e\n\u003ctd\u003eMaintain above 850% given 2026 COGS of 120%\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eCapacity Utilization Rate (CUR)\u003c\/td\u003e\n\u003ctd\u003eUtilization\u003c\/td\u003e\n\u003ctd\u003ePush all roles, especially Case Management (starting at 500%), toward 850%\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eAverage Revenue Per Case (ARPC)\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eMaintain or increase the average price year-over-year\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eMinimum Cash Requirement\u003c\/td\u003e\n\u003ctd\u003eCash Flow\u003c\/td\u003e\n\u003ctd\u003ePlan financing to cover the -$1,305,000 minimum cash needed by June 2026\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eEBITDA Growth Rate\u003c\/td\u003e\n\u003ctd\u003eProfitability\u003c\/td\u003e\n\u003ctd\u003eAchieve strong growth, moving from $17M in Year 1 to $200M in Year 5\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eCost of Goods Sold (COGS) Percentage\u003c\/td\u003e\n\u003ctd\u003eCost Control\u003c\/td\u003e\n\u003ctd\u003eMaintain below 120% (2026 start) and seek efficiency to reach 105% by 2030\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eStaff Productivity Index\u003c\/td\u003e\n\u003ctd\u003eEfficiency\u003c\/td\u003e\n\u003ctd\u003eIncrease cases per FTE annually (eg, Forensic Scientist 30 cases\/month in 2026 to 35 in 2030)\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the minimum viable capacity utilization rate needed to sustain operations?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe minimum viable capacity utilization for the Rapid DNA Testing service hinges on covering \u003cstrong\u003e$49,000\u003c\/strong\u003e in baseline costs while scaling volume to meet the aggressive \u003cstrong\u003e880%\u003c\/strong\u003e gross margin target; honestly, if your bottleneck staff are running at 500% capacity, you're already overloaded before you hit profit targets, defintely requiring immediate action.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eStaff Overload \u0026amp; Cost Coverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAnalyze Case Management Coordinators utilization, noting the starting point is \u003cstrong\u003e500%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis utilization means staff are handling \u003cstrong\u003e5.0 times\u003c\/strong\u003e the expected workload per shift.\u003c\/li\u003e\n\u003cli\u003eCalculate the monthly revenue required to absorb \u003cstrong\u003e$49,000\u003c\/strong\u003e in fixed costs plus salaries.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises significantly for new clients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Target Volume\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDetermine the necessary case volume to achieve the \u003cstrong\u003e880%\u003c\/strong\u003e target gross margin.\u003c\/li\u003e\n\u003cli\u003eThis margin implies revenue must be \u003cstrong\u003e9.8 times\u003c\/strong\u003e the cost of goods sold (COGS).\u003c\/li\u003e\n\u003cli\u003eYou must secure enough volume to cover the \u003cstrong\u003e$49,000\u003c\/strong\u003e hurdle while maintaining high pricing integrity.\u003c\/li\u003e\n\u003cli\u003eFocus operatons on maximizing throughput per coordinator to reduce the effective cost per test.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow quickly can we recover the significant initial capital investment?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eRecovery hinges on hitting the \u003cstrong\u003e19 months\u003c\/strong\u003e payback target while managing the \u003cstrong\u003e$2,900,000+\u003c\/strong\u003e initial CAPEX for instruments and build-out; this requires EBITDA growth from \u003cstrong\u003e$17M\u003c\/strong\u003e in Year 1 up to \u003cstrong\u003e$200M\u003c\/strong\u003e by Year 5, which you can defintely map out using guidance on \u003ca href=\"\/blogs\/write-business-plan\/rapid-dna-testing-laboratories\"\u003eWhat Are The Key Sections To Include In Your Business Plan For Rapid DNA Testing Startup?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTrack Initial Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMonitor the \u003cstrong\u003e$2,900,000+\u003c\/strong\u003e initial CAPEX closely.\u003c\/li\u003e\n\u003cli\u003eAccount for costs related to instruments and facility build-out.\u003c\/li\u003e\n\u003cli\u003eThe target payback period for this investment is \u003cstrong\u003e19 months\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eOperational efficiency must drive quick recovery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eEnsure EBITDA Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eYear 1 EBITDA must reach \u003cstrong\u003e$17M\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe goal is scaling EBITDA to \u003cstrong\u003e$200M\u003c\/strong\u003e by Year 5.\u003c\/li\u003e\n\u003cli\u003eEBITDA growth must outpace the initial capital deployment rate.\u003c\/li\u003e\n\u003cli\u003eTest volume directly impacts the ability to hit these profit milestones.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhich service lines drive the highest revenue density and margin?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Forensic DNA Scientist service drives superior revenue density because its \u003cstrong\u003e$1,500 AOV\u003c\/strong\u003e dwarfs the $500 AOV of the high-volume Molecular Lab Technician work, so sales must target the high-value niche; for founders looking at this structure, understanding how to structure operations is key, as detailed in \u003ca href=\"\/blogs\/how-to-open\/rapid-dna-testing-laboratories\"\u003eHow Can You Effectively Launch Rapid DNA Testing Business To Serve Law Enforcement And Forensics?\u003c\/a\u003e. Defintely focus sales efforts on maximizing utilization of the most expensive analytical equipment, which supports those higher fees.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Density Comparison\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eScientist AOV is \u003cstrong\u003e3x higher\u003c\/strong\u003e ($1,500 vs. $500).\u003c\/li\u003e\n\u003cli\u003eTechnician volume at 150 cases\/month yields $75,000 monthly revenue.\u003c\/li\u003e\n\u003cli\u003eThe $1,500 service generates revenue faster per case processed.\u003c\/li\u003e\n\u003cli\u003ePrioritize services that command the highest price point.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eAsset Utilization Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eHigh AOV work usually ties to \u003cstrong\u003epremium, fixed equipment costs\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFocus sales on complex investigations requiring the best machinery.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises for high-value clients.\u003c\/li\u003e\n\u003cli\u003eVolume alone at $500 AOV may not cover high capital expenditure quickly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre we effectively managing the variable costs tied to data security and compliance?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eManaging variable costs for the Rapid DNA Testing service hinges on aggressively reducing specialized security and training expenses from \u003cstrong\u003e50% of revenue in 2026\u003c\/strong\u003e down to \u003cstrong\u003e40% by 2030\u003c\/strong\u003e, a challenge similar to those faced when considering how \u003ca href=\"\/blogs\/how-to-open\/rapid-dna-testing-laboratories\"\u003eHow Can You Effectively Launch Rapid DNA Testing Business To Serve Law Enforcement And Forensics?\u003c\/a\u003e. This requires process optimization to maintain accreditation standards while scaling throughput; defintely watch utilization rates here.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eInitial Variable Cost Load\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSecurity and training costs start at \u003cstrong\u003e50% of revenue\u003c\/strong\u003e in 2026.\u003c\/li\u003e\n\u003cli\u003eThese costs cover specialized access protocols and mandatory annual certifications.\u003c\/li\u003e\n\u003cli\u003eThis high initial percentage suggests current processes aren't fully optimized for volume.\u003c\/li\u003e\n\u003cli\u003eVariable costs scale directly with the number of tests processed and staff hours logged.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTargeting Cost Compression\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe goal is a \u003cstrong\u003e10-point reduction\u003c\/strong\u003e in this cost ratio by 2030.\u003c\/li\u003e\n\u003cli\u003eThis means achieving \u003cstrong\u003e40% of revenue\u003c\/strong\u003e for security and training five years later.\u003c\/li\u003e\n\u003cli\u003eLook at automating compliance reporting to lower administrative training overhead.\u003c\/li\u003e\n\u003cli\u003eEnsure new hires achieve full productivity within \u003cstrong\u003e30 days\u003c\/strong\u003e to lower onboarding cost per test.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eManaging the substantial initial CAPEX of over $29 million requires immediate focus on covering the projected minimum cash need of -$1.305 million by mid-2026.\u003c\/li\u003e\n\n\u003cli\u003eProfitability hinges directly on maximizing Capacity Utilization Rates across all roles, especially bottleneck staff starting at utilization rates as high as 500%.\u003c\/li\u003e\n\n\u003cli\u003eThe 19-month payback period must be closely monitored to confirm the recovery timeline for the significant initial capital investment in instruments and lab build-out.\u003c\/li\u003e\n\n\u003cli\u003eTo sustain the high gross margin target above 85%, operational focus must remain on controlling COGS (starting at 120%) and ensuring security costs decrease as a percentage of revenue.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin Percentage\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage measures profitability after paying for the direct costs of running a DNA analysis. It shows what percentage of revenue is left over before accounting for rent, salaries, and marketing. This metric is defintely key for setting service prices and managing lab supply costs.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows true unit profitability of each case processed.\u003c\/li\u003e\n\u003cli\u003eGuides decisions on supplier contracts for kits and reagents.\u003c\/li\u003e\n\u003cli\u003eDirectly impacts the cash available to cover fixed overhead costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores critical fixed costs like specialized equipment leases.\u003c\/li\u003e\n\u003cli\u003eCan mask inefficiencies if Cost of Goods Sold (COGS) tracking is poor.\u003c\/li\u003e\n\u003cli\u003eA high percentage doesn't guarantee overall business success if volume is too low.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor high-value, accredited service providers like forensic labs, Gross Margin Percentage should generally sit well above 60%. Since your model relies on high-priced, low-volume specialized services, aiming for margins near 80% is realistic if material costs are controlled. You must review this monthly to ensure pricing keeps pace with reagent inflation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate bulk pricing for DNA testing kits and reagents.\u003c\/li\u003e\n\u003cli\u003eIncrease Average Revenue Per Case (ARPC) through premium service tiers.\u003c\/li\u003e\n\u003cli\u003eImprove Capacity Utilization Rate (CUR) to spread fixed lab setup costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate Gross Margin Percentage by taking total revenue, subtracting the direct costs associated with delivering that revenue (COGS), and dividing the result by total revenue. Your target is aggressive: maintain above \u003cstrong\u003e850%\u003c\/strong\u003e, even though your 2026 COGS projection is \u003cstrong\u003e120%\u003c\/strong\u003e of revenue. This requires immediate review of that target structure.\u003c\/p\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay you billed $500,000 in revenue last month, and the direct costs for reagents, consumables, and technician time directly tied to those tests totaled $60,000. This aligns with the \u003cstrong\u003e120%\u003c\/strong\u003e COGS target if interpreted as 12% COGS, not 120%.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n($500,000 Revenue - $60,000 COGS) \/ $500,000 Revenue = 0.88 or \u003cstrong\u003e88% Gross Margin Percentage\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your COGS was truly 120% of revenue ($600,000), your margin would be negative 20%, which is why that \u003cstrong\u003e850%\u003c\/strong\u003e target needs immediate reconciliation against the \u003cstrong\u003e120%\u003c\/strong\u003e COGS input.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack COGS monthly against the \u003cstrong\u003e120%\u003c\/strong\u003e 2026 projection.\u003c\/li\u003e\n\u003cli\u003eEnsure technician time allocation is accurately assigned to COGS, not overhead.\u003c\/li\u003e\n\u003cli\u003eIf margins dip below 75%, raise pricing for non-contracted clients immediately.\u003c\/li\u003e\n\u003cli\u003eUse the Staff Productivity Index to drive down per-case labor costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eCapacity Utilization Rate (CUR)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCapacity Utilization Rate (CUR) measures how much of your available staff or equipment time you are actually using to process DNA tests. This is critical because your revenue depends entirely on throughput, and high fixed lab costs demand maximum usage. For Veritas Rapid Labs, CUR shows if you are maximizing the speed advantage you promise clients.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoints operational bottlenecks before they slow down case resolution times.\u003c\/li\u003e\n\u003cli\u003eDirectly links resource deployment to potential revenue generation capacity.\u003c\/li\u003e\n\u003cli\u003eGuides smart investment decisions on new testing equipment or hiring plans.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eExtremely high targets, like \u003cstrong\u003e850%\u003c\/strong\u003e, can mask quality control failures in sensitive forensic work.\u003c\/li\u003e\n\u003cli\u003eIt doesn't account for case complexity; a simple identity confirmation takes less time than a complex legal investigation.\u003c\/li\u003e\n\u003cli\u003eSustaining high utilization often requires staff to work beyond sustainable limits, increasing burnout risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn traditional manufacturing, a good CUR is usually between \u003cstrong\u003e75%\u003c\/strong\u003e and \u003cstrong\u003e85%\u003c\/strong\u003e of available time. Your targets are different because you are measuring efficiency against a baseline task load, not just time spent. Hitting \u003cstrong\u003e500%\u003c\/strong\u003e utilization for Case Management means that role is handling five times the standard workload, which is a throughput metric, not a time clock.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStreamline intake protocols with law enforcement partners to reduce Case Management rework time.\u003c\/li\u003e\n\u003cli\u003eOptimize lab scheduling to run high-volume, similar tests in continuous batches.\u003c\/li\u003e\n\u003cli\u003eCross-train technical staff to cover immediate shortfalls in specialized testing queues.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate CUR by dividing the actual number of cases you successfully processed by the maximum number of cases your current setup is designed to handle in that period. This shows the percentage of your theoretical maximum output you are actually achieving.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCUR = Actual Cases Processed \/ Maximum Capacity\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your lab infrastructure is set up to handle a baseline of \u003cstrong\u003e100\u003c\/strong\u003e legally admissible tests per day, which is your Maximum Capacity. If your team manages to process \u003cstrong\u003e850\u003c\/strong\u003e units of work (factoring in the multiplier effect for efficiency gains) in a day, your utilization is extremely high.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCUR = 850 Actual Cases Processed \/ 100 Maximum Capacity = \u003cstrong\u003e850%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis \u003cstrong\u003e850%\u003c\/strong\u003e figure tells you that you are operating far beyond the standard single-case load, which is the goal for scaling revenue quickly.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview CUR \u003cstrong\u003eweekly\u003c\/strong\u003e; this metric demands fast reaction time to maintain speed promises.\u003c\/li\u003e\n\u003cli\u003eFocus first on the Case Management role; if they lag below \u003cstrong\u003e500%\u003c\/strong\u003e, the lab gets starved of work.\u003c\/li\u003e\n\u003cli\u003eTrack utilization separately for lab equipment versus administrative staff for targeted fixes.\u003c\/li\u003e\n\u003cli\u003eIf utilization spikes above \u003cstrong\u003e900%\u003c\/strong\u003e, flag it for quality review; defintely check for rushed procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eAverage Revenue Per Case (ARPC)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAverage Revenue Per Case (ARPC) shows the average dollar amount you collect for every single DNA analysis performed. This metric is vital because it tells you if your pricing strategy is working across all your different service tiers. You need to watch this defintely on a monthly basis to ensure you aren't drifting toward lower-value work without realizing it.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eValidates if current pricing covers high fixed costs for rapid turnaround.\u003c\/li\u003e\n\u003cli\u003eHighlights which service types are generating the most revenue per unit processed.\u003c\/li\u003e\n\u003cli\u003eShows if price increases are sticking without causing a drop in case volume.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt masks underlying volume problems if total revenue stays flat.\u003c\/li\u003e\n\u003cli\u003eA rising ARPC might hide a shift away from complex, high-value cases.\u003c\/li\u003e\n\u003cli\u003eIt doesn't reflect the actual time or cost required to complete that average case.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized, legally-admissible forensic services like yours, ARPC should be significantly higher than general clinical testing rates. Benchmarks are hard to set without knowing the exact mix of 90-minute vs. standard tests. Still, you should compare your ARPC against the blended rate of similar accredited labs serving government contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eImplement tiered pricing based on turnaround time (e.g., premium for 90-minute results).\u003c\/li\u003e\n\u003cli\u003eBundle standard analysis with expedited report delivery or expert consultation fees.\u003c\/li\u003e\n\u003cli\u003eReview contracts with large clients to ensure pricing reflects current operational demands.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCalculating ARPC is straightforward: divide your total monthly income by the number of tests you finished that month. You must use the total revenue figure, not just revenue from one service type. This gives you the true blended price point.\u003c\/p\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your lab brought in $196,000 last month while processing 250 cases, the ARPC is calculated as follows. This shows the average realization per case.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eTotal Monthly Revenue \/ Total Cases Processed\u003c\/div\u003e\n\u003cp\u003eUsing the example figures:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e$196,000 \/ 250 cases = $784 per case\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSegment ARPC by client type: law enforcement versus private legal firms.\u003c\/li\u003e\n\u003cli\u003eTrack the target: Maintain or increase the average price year-over-year.\u003c\/li\u003e\n\u003cli\u003eIf ARPC drops, check Capacity Utilization Rate (CUR) immediately for context.\u003c\/li\u003e\n\u003cli\u003eEnsure scope creep on existing cases doesn't artificially lower the average realization.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eMinimum Cash Requirement\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eMinimum Cash Requirement (MCR) is the lowest point your bank account balance is projected to hit before the business generates enough positive cash flow to sustain itself. It measures the peak negative cash flow needed to cover all operating expenses and capital expenditures (CAPEX). You calculate this by tracking your monthly cash balance projection, which tells you exactly how much money you need to raise.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSets the precise minimum capital raise required for survival.\u003c\/li\u003e\n\u003cli\u003eEnsures you don't run out of money during the initial operational ramp-up phase.\u003c\/li\u003e\n\u003cli\u003eProvides a clear, non-negotiable milestone for investor discussions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIt is highly sensitive to initial assumptions about case volume and utilization.\u003c\/li\u003e\n\u003cli\u003eCan lead to over-funding if the projected burn rate is too conservative.\u003c\/li\u003e\n\u003cli\u003eIt doesn't inherently account for unexpected delays in securing permits or equipment installation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized, high-CAPEX service startups like rapid DNA testing, the MCR often equates to \u003cstrong\u003e12 to 18 months\u003c\/strong\u003e of projected negative cash flow. Benchmarks are less useful here than internal modeling because the cost of setting up accredited lab space varies significantly by location. What matters is covering the specific peak deficit identified in your model, which for you is \u003cstrong\u003e-$1,305,000\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDefer non-essential capital expenditures by leasing specialized testing equipment initially.\u003c\/li\u003e\n\u003cli\u003eAccelerate revenue by negotiating faster payment terms with law enforcement clients.\u003c\/li\u003e\n\u003cli\u003eAggressively drive Capacity Utilization Rate (CUR) toward \u003cstrong\u003e850%\u003c\/strong\u003e to reduce the monthly cash burn faster.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe MCR is the lowest point on your cumulative cash flow projection line. You track the running cash balance month-by-month, factoring in all expenses, CAPEX, and revenue inflows. The MCR is the absolute lowest negative number reached during this projection period.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eMCR = MIN(Cumulative Monthly Cash Balance)\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must plan your financing to ensure you have enough capital to survive the deepest cash deficit shown in your model. For Veritas Rapid Labs, the model shows the cash balance dipping to its lowest point in \u003cstrong\u003eJune 2026\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eProjected Minimum Cash Balance (June 2026) = -$1,305,000\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview the projected MCR monthly, as your plan requires, to catch deviations early.\u003c\/li\u003e\n\u003cli\u003eAlways add a \u003cstrong\u003e20% contingency buffer\u003c\/strong\u003e to the calculated -$1,305,000 figure for safety.\u003c\/li\u003e\n\u003cli\u003eMap financing tranches directly to the MCR timeline to ensure funds arrive before the peak deficit.\u003c\/li\u003e\n\u003cli\u003eWatch Cost of Goods Sold (COGS) Percentage; if it rises above the \u003cstrong\u003e120%\u003c\/strong\u003e target, the MCR will increase defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eEBITDA Growth Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEBITDA Growth Rate measures how fast your core operational profitability is expanding before accounting for debt, taxes, or asset write-downs. This metric tells founders and investors if the fundamental service delivery model—processing accredited DNA tests—is scaling efficiently. For Veritas Rapid Labs, it tracks the acceleration of profit derived purely from case volume, ignoring financing decisions.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFocuses management purely on operational efficiency, like case throughput and pricing power.\u003c\/li\u003e\n\u003cli\u003eAllows clean comparison of scaling performance against peers, regardless of capital structure.\u003c\/li\u003e\n\u003cli\u003eDirectly measures success in hitting aggressive targets, like moving from \u003cstrong\u003e$17M\u003c\/strong\u003e in Year 1 to \u003cstrong\u003e$200M\u003c\/strong\u003e by Year 5.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores significant capital expenditure needs for state-of-the-art lab equipment.\u003c\/li\u003e\n\u003cli\u003eCan mask poor cash management if working capital requirements balloon during rapid growth.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for interest expense, which matters if you take on debt to fund expansion.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor high-growth, specialized service providers like forensic labs, investors look for EBITDA growth rates well above \u003cstrong\u003e50%\u003c\/strong\u003e annually in the early scaling phase. Achieving the target growth rate here means scaling operational profit by over \u003cstrong\u003e1000%\u003c\/strong\u003e in four years. These benchmarks signal market acceptance and the ability to manage variable costs effectively as volume increases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAggressively increase \u003cstrong\u003eCapacity Utilization Rate (CUR)\u003c\/strong\u003e above the \u003cstrong\u003e850%\u003c\/strong\u003e target for case management roles.\u003c\/li\u003e\n\u003cli\u003eDrive up \u003cstrong\u003eAverage Revenue Per Case (ARPC)\u003c\/strong\u003e by prioritizing higher-margin legal investigations.\u003c\/li\u003e\n\u003cli\u003eReduce \u003cstrong\u003eCOGS Percentage\u003c\/strong\u003e below the \u003cstrong\u003e120%\u003c\/strong\u003e starting point through bulk purchasing of reagents.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue\n_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate the growth rate by taking the current period's EBITDA, subtracting the prior period's EBITDA, and dividing that difference by the prior period's figure. This must be reviewed \u003cstrong\u003eQuarterly\u003c\/strong\u003e to ensure the path from \u003cstrong\u003e$17M\u003c\/strong\u003e to \u003cstrong\u003e$200M\u003c\/strong\u003e remains on track.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n(Current EBITDA - Prior EBITDA) \/ Prior EBITDA\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay Year 1 EBITDA was \u003cstrong\u003e$17,000,000\u003c\/strong\u003e and management projects Year 2 EBITDA to hit \u003cstrong\u003e$40,000,000\u003c\/strong\u003e based on increased utilization. The resulting growth rate shows the speed of operational scaling between those two years.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\n($40,000,000 - $17,000,000) \/ $17,000,000 = \u003cstrong\u003e135.3%\u003c\/strong\u003e Growth Rate\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric \u003cstrong\u003equarterly\u003c\/strong\u003e, as mandated, to catch deviations early.\u003c\/li\u003e\n\u003cli\u003eAlways reconcile EBITDA changes against the \u003cstrong\u003eStaff Productivity Index\u003c\/strong\u003e changes.\u003c\/li\u003e\n\u003cli\u003eEnsure depreciation schedules don't artificially depress EBITDA during high CAPEX phases.\u003c\/li\u003e\n\u003cli\u003eTrack the growth rate against the \u003cstrong\u003eMinimum Cash Requirement\u003c\/strong\u003e timeline; rapid growth burns cash fast.\u003c\/li\u003e\n\u003cli\u003eIf utilization stalls, EBITDA growth will stall; defintely watch Capacity Utilization Rate weekly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eCost of Goods Sold (COGS) Percentage\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCost of Goods Sold (COGS) Percentage shows the direct cost of materials—like the testing kits and reagents—compared to the money you bring in from running a test. For a service like accredited DNA analysis, this metric is vital because it directly measures the efficiency of your core lab process. If this number is too high, you aren't making enough margin on each service delivery.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoints material waste in lab processes, like reagent overuse.\u003c\/li\u003e\n\u003cli\u003eHelps set minimum profitable pricing for new, complex test offerings.\u003c\/li\u003e\n\u003cli\u003eShows the immediate impact of supplier price changes on gross profit.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores critical fixed costs like specialized technician salaries and depreciation.\u003c\/li\u003e\n\u003cli\u003eCan be misleading if test complexity varies widely across law enforcement versus family law cases.\u003c\/li\u003e\n\u003cli\u003eDoesn't reflect the true cost of delivering the final, legally-admissible report package.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor high-throughput diagnostic services, a healthy COGS percentage is often below 50%. Your initial target of keeping it below \u003cstrong\u003e120%\u003c\/strong\u003e starting in 2026 suggests you anticipate high initial material costs relative to your early service fees, or perhaps the initial pricing structure is conservative. You need to drive this down toward \u003cstrong\u003e105%\u003c\/strong\u003e by 2030 to build sustainable gross profit margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate volume discounts with primary kit and reagent suppliers now.\u003c\/li\u003e\n\u003cli\u003eStandardize testing protocols to reduce material waste per case processed.\u003c\/li\u003e\n\u003cli\u003eIncrease throughput (cases\/day) to lower the per-unit material cost absorption.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find your Cost of Goods Sold Percentage, you divide the total cost of the physical items used to run the tests by the total revenue generated from those tests. This ratio tells you what percentage of every dollar earned goes straight back out for materials. You must review this defintely on a \u003cstrong\u003emonthly\u003c\/strong\u003e basis.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCOGS Percentage = Total COGS \/ Total Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay in the first quarter of 2026, your lab processed enough tests to bring in \u003cstrong\u003e$250,000\u003c\/strong\u003e in revenue. If the kits, reagents, and consumables used for those specific tests cost you \u003cstrong\u003e$300,000\u003c\/strong\u003e, here is the math. This scenario shows you are starting above your target, which is expected for rapid scaling.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCOGS Percentage = $300,000 \/ $250,000 = 1.20 or \u003cstrong\u003e120%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack this metric \u003cstrong\u003emonthly\u003c\/strong\u003e for immediate course correction on material spend.\u003c\/li\u003e\n\u003cli\u003eEnsure COGS only includes direct materials; technician labor is an operating expense.\u003c\/li\u003e\n\u003cli\u003eIf you exceed \u003cstrong\u003e120%\u003c\/strong\u003e, immediately audit the last 50 tests for material over-use or incorrect kit usage.\u003c\/li\u003e\n\u003cli\u003eModel the impact of supplier price hikes on your 2030 goal of \u003cstrong\u003e105%\u003c\/strong\u003e efficiency.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eStaff Productivity Index\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Staff Productivity Index measures how much case volume your core technical staff handles. It tells you if you’re getting more output from your \u003cstrong\u003eForensic Scientists\u003c\/strong\u003e, \u003cstrong\u003eLab Techs\u003c\/strong\u003e, and \u003cstrong\u003eAnalysts\u003c\/strong\u003e without adding headcount. This is crucial because high productivity means you can scale revenue without immediately increasing your fixed payroll costs.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDirectly links labor efficiency to operational leverage.\u003c\/li\u003e\n\u003cli\u003eHighlights where process improvements yield the biggest return.\u003c\/li\u003e\n\u003cli\u003eInforms precise hiring schedules to manage cash flow better.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCan pressure staff to rush, risking critical errors in analysis.\u003c\/li\u003e\n\u003cli\u003eIgnores necessary time spent on training or quality assurance checks.\u003c\/li\u003e\n\u003cli\u003eDoesn't differentiate between simple identity checks and complex evidence review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor specialized forensic services, benchmarks aren't static dollar figures; they are growth trajectories. You need to compare your year-over-year improvement rate against industry peers who are also adopting faster testing methods. If your competitors are achieving \u003cstrong\u003e5% annual productivity gains\u003c\/strong\u003e, you must match or exceed that just to stay competitive on cost structure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAutomate repetitive pre-processing steps to free up scientist time.\u003c\/li\u003e\n\u003cli\u003eImplement standardized operating procedures (SOPs) across all labs.\u003c\/li\u003e\n\u003cli\u003eInvest in better Laboratory Information Management Systems (LIMS) software.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by dividing the total number of cases closed in a period by the total number of full-time equivalents (FTEs) dedicated solely to technical work. Remember, this excludes admin staff and management—we only care about the people running the tests.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nStaff Productivity Index = Total Cases \/ Total Technical FTEs\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-2\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49304060395763,"sku":"rapid-dna-testing-laboratories-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/rapid-dna-testing-laboratories-kpi-metrics.webp?v=1782690574","url":"https:\/\/financialmodelslab.com\/products\/rapid-dna-testing-laboratories-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}